| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 3,671,865 | 3,391,823 | 3,417,428 | 4,089,727 | | Cost of Revenue | 3,250,804 | 2,989,629 | 2,986,432 | 3,569,631 | | | Gross Profit | 421,061 | 402,194 | 430,996 | 520,096 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 321,503 | 315,028 | 329,114 | 376,368 | | Non Recurring | 37,583 | 19,252 | 24,018 | 1,061,083 | | Others | 16,919 | 16,716 | 16,627 | 17,091 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,056 | 51,198 | 61,237 | (934,446) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,312) | (1,631) | 1,631 | (13,389) | | Earnings Before Interest And Taxes | 41,627 | 50,594 | 63,191 | (946,645) | | Interest Expense | 18,033 | 15,451 | 24,666 | 22,494 | | Income Before Tax | 23,594 | 35,143 | 38,525 | (969,139) | | Income Tax Expense | 11,018 | 14,061 | 11,789 | (97,079) | | Minority Interest | 25 |
-
|
-
| 165 | | | | Net Income From Continuing Ops | 12,601 | 21,082 | 26,736 | (871,895) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,601 | 21,082 | 26,736 | (871,895) | | Preferred Stock And Other Adjustments | (20) | 15 | 5 |
-
| | | Net Income Applicable To Common Shares | $12,581 | $21,097 | $26,741 | ($871,895) |
|
0.40% Nasdaq 
Income Statement
